Iron therapy alone or in combination with erythropoietin in surgical and medical cardiac patients

Mercè Cladellas, Jordi Bruguera, Josep Comín-Colet

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

Anemia has been associated to poor outcomes in the whole spectrum of patients with heart disease. The etiology of this comorbidity in cardiac patients is multifactorial but acute bleeding or chronic occult blood loss, iron deficiency and inflammation are common causes in these patients. Abnormal handling or availability of iron and inadequate response to endogenous erythropoietin have both raised the interest of researchers and clinicians to explore the therapeutic role of these agents either alone or in combination. In this review, we analyze the most recent research evaluating the role of iron alone or in combination with erythropoietin in the management of anemia of cardiac patients ranging from those patients that undergo cardiac surgery to those more advanced patients with chronic heart failure. © 2012 Medical Education Global Solutions.
Original languageEnglish
Pages (from-to)143-149
JournalTransfusion Alternatives in Transfusion Medicine
Volume12
Issue number3-4
DOIs
Publication statusPublished - 1 Dec 2012

Keywords

  • Anemia
  • Cardiac surgery
  • Chronic heart failure
  • Erythropoietin
  • Iron deficiency
  • Iron therapy

Fingerprint Dive into the research topics of 'Iron therapy alone or in combination with erythropoietin in surgical and medical cardiac patients'. Together they form a unique fingerprint.

Cite this